Visium Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,307,132
Closed -$6.81M 1053
2013
Q3
$6.81M Sell
1,307,132
-42,868
-3% -$188K 0.15% 109
2013
Q2
$4.87M Buy
+1,350,000
New +$5.52M 0.11% 134

Visium Asset Management's IDIX Position: Q4 2013 in Review

Visium Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q4 2013, closing a stake of 1,307,132 shares — an estimated $6.81M sold.

Visium Asset Management first reported a position in IDIX in Q2 2013 and held it in 2 quarters. The position peaked at $6.81M in Q3 2013. 88 funds tracked by Wall St. Rank hold IDIX as of Q4 2013.

  • Visium Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Visium Asset Management sold 1,307,132 IDENIX PHARMACEUTICALS INC shares in Q4 2013, an estimated $6.81M.
  • Visium Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Visium Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $6.81M in Q3 2013.
  • 88 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q4 2013.

Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.